Mary Thistle - Apr 18, 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Director
Signature
/s/ Jennifer Ziolkowski, Attorney-in-Fact
Stock symbol
VIGL
Transactions as of
Apr 18, 2022
Transactions value $
$0
Form type
4
Date filed
4/20/2022, 06:02 PM
Previous filing
Oct 28, 2021
Next filing
Jun 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Grant (Right to Buy) Award $0 +24.3K $0.00 24.3K Apr 18, 2022 Common Stock 24.3K $6.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest and become exercisable on April 18, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.